THU0588 ARE RHEUMATOID ARTHRITIS PATIENTS WILLING TO USE AN E-HEALTH INTERACTIVE SELF-ASSESSMENT WEBSITE? ANALYSES OF 159 PATIENTS FROM A RANDOMISED CONTROLLED TRIAL OVER 12 MONTHS
Background: Interactive, online electronic (e)-health services with patientreported outcome measure (PROM)-based instruments may be helpful for patients (pts). Sanoïa is a secure, independent e-and mobile (m)-health platform developed to allow pt self-assessment, storage of questions to ask physicians, and self-monitoring of disease status. The platform offers a dedicated set of scores, PROMs and information about different diseases, including rheumatoid arthritis (RA). Objectives: To characterise pts with RA who chose to access e-health services regularly over a 12-month (mo) period. Methods: Post-hoc analysis of CarNET (NCT02200068): a French, multicentre, 12-mo randomised controlled trial. Pts with RA were randomised to: access to Sanoïa (30-min training via the telephone with no further incentive to access the platform) or usual care (normal internet use without access to Sanoïa). The Sanoïa group pts used a home-based e-Case Report Form to record frequency of Sanoïa access, satisfaction with the platform (0-10 scale; 0=completely satisfied, 10=not satisfied), and barriers to use (from a pre-specified list Objectives: This analysis explored pt-perceived quality levels of pt-phy interactions and characteristics of pts when these interactions are described as very good by pts. Methods: CarNET (NCT02200068) was a French, 12-month, multicentre randomised controlled trial to assess access to an e-health platform (Sanoïa) allowing self-assessment of disease.
1,2 This was a post-hoc analysis, using baseline data only. Pts had confirmed RA and were enrolled by their treating rheumatologist. Pt-perceived pt-phy interactions were assessed through the pt-reported questionnaire Perceived Efficacy in Patient-Physician Interactions 3 which consists of 5 items, each starting with "How confident are you in your ability to ..." (eg. "... know what questions to ask a doctor?"). Pts rated each item on an 11-point scale; 0=not at all confident, 10=very confident. Total PEPPI-5 scores range from 0-50; higher scores represent higher perceived self-efficacy in pt-phy interactions. Factors associated with a higher PEPPI-5 (ie. >median) were analysed by univariate and multivariate logistic regression (factors included pt demographics, phy demographics, disease characteristics and activity including pt-perceived coping [scored 0-10 in the Rheumatoid Arthritis Impact of Disease (RAID) questionnaire; lower scores indicate better coping]). Results: Of 320 RA pts (159 vs 161; Sanoïa vs usual care), mean±SD age was 57.0±12.7 years, disease duration was 14.6±11.1 years and 253 (79.1%) were female. Mean DAS28 was 2.7±1.2, 54.1% were in DAS28 remission (<2.6); 216 (67.5%) were taking a biologic; 21.9% had previous therapeutic education sessions; 15.3% were members of pt associations; and 51.9% had followed university-level studies. The mean±SD PEPPI-5 score was 39.2±7.8 and the median was 40. In univariate analyses, associations with p<0.05 were observed between pt-perceived coping (p=0.0008), erosive disease (p=0.03) and DAS28 remission (p=0.05) and a high PEPPI-5; associations with p<0.2 were observed for older age (p=0.07) and HAQ-DI≤0.5 (p=0.12). In multivariate analyses, the only factor associated with high PEPPI-5 was pt-perceived coping (odds ratio [95% CI]=0.85 [0.76-0.96]; p=0.007). Conclusions: Among RA pts whose disease was well controlled, pt-perceived pt-phy interactions were good. Pt-perceived coping was associated with better pt-perceived pt-phy interactions, indicating that perhaps pts who felt in control were more at ease with their phy, or vice-versa. The data did not allow us to attribute causality. These elements are important in the shared decision-making process. Background: Portfolios are increasingly used in medical education. A portfolio may stimulate deep learning, deliver summative assessment and encourage reflection on clinical practice. A portfolio is seen as the key connection between learning at the organizational and the individual level. Objectives: To (1) explore the perceptions of young rheumatologists about the use of a portfolio and to (2) study the barriers and facilitators when implementing a portfolio at a national and international level. Methods: A survey was sent by email to all EMEUNET (Emerging EULAR Network) members. EMEUNET is a group of young rheumatologists and researchers within EULAR-member countries. Descriptive statistics were used to analyse initial data collected (Nov-Dec 2016). Weighted averages were calculated (i.e. mean in which each item being averaged is multiplied by a number (weight) based on the item's relative importance). Results: 132 participants responded (64% female; mean age 33.5 years (SD 4.3 years); 34 countries). In total, 56.3% of participants were working as rheumatologists; 32.8% were rheumatologists in training. 49.6% of the participants indicated that a portfolio was already used by rheumatology fellows working at their institution; in 71.9% of these cases, this portfolio was also used at a national level. 50.4% of participants did not use a portfolio during their training; of these, 86.7% (strongly) agreed that a portfolio might be a useful tool. Several barriers for successful implementation of a portfolio were identified by the participants. The main barrier was that a portfolio was not developed at a national level, and if developed at a national level, there were often no incentives to use it (Table 1) . According to participants, the top 3 competencies that should be collected and reflected upon in the portfolio were (weighted average; importance 0 (not important) -10 (extremely important)): practical skills (e.g. ultrasound) (8.2); correct use of diagnostics and therapeutic armamentarium (7.9); clinical skills (e.g. history taking) (7.8). The skills chosen as the least important to be included in a portfolio were: information on management tasks (6.5); promoting hospital-based care (e.g. writing a protocol) (6.6); theoretical and clinical knowledge (6.7). Conclusions: A portfolio is generally considered a valuable tool and half of the participants already work with it. However, several barriers may prevent optimal implementation. Developing a core set of rheumatology-oriented competencies and a template for a portfolio to be used across institutions and eventually countries could promote implementation and harmonize training. Background: Literacy is "the ability to read and use written information and to write appropriately in a range of contexts".
References
1 Low literacy is associated with poorer health outcomes, including increased mortality.
2 Those accessing the healthcare system require adequate literacy to understand written instructions regarding medication, appointments and medication doses. We have previously shown in >200 rural and urban Rheumatology patients that <15% of patients had low health literacy and <1/3 of patients incorrectly followed dosing instructions for common Rheumatology drugs.
3 Up to 24% of US Rheumatology patients had a reading level of ≤8th grade. 4 These findings are concerning, as Rheumatologists often use medications such as MTX or bDMARDS with severe side effects. Rheumatologists often provide written information regarding these medications to patients. Objectives: To assess i) the readability of Patient Medicine Information Sheets (PMIS) regarding medications provided to patients by Australian Rheumatologists, and ii) patient comprehension of these documents. Methods: Thirty-one English-language PMIS from the Australian Rheumatology Association (ARA) website were assessed for readability using Readability Studio TM (Oleander Software) . This software uses the number of sentences, words, syllables and characters in a sample of writing to estimate the required grade level and reading age of the target population using several readability scales (eg Flesch scale, Gunning Fog and Simple Measure of Gobbledygook, or SMOG). To assess comprehension, a random sample of 100 patients from MNCAC was asked to read an ARA PMIS about one of the following medications: MTX, NSAIDS, Adalimumab, Abatacept or prednisone. He/she then answered five multiple choice questions about the content. A time limit of 15 minutes for reading the PMIS and answering the questions was allowed.Approval was obtained from the local HREC as a low/negligible risk project. Results are expressed as mean ± sem. Results: The mean Flesch scale value (range 0-100, 0=very confusing; 100=very easy) of the 31 PMIS assessed was 51.1±0.6 (fairly difficult). The mean FORCAST grade level and reader age was 11±0 and 16-17 years, respectively. The mean Gunning Fog grade level was 11.4±0.1 with a reader age of 16-17 years. The mean SMOG grade level was 11.8±0.1 with a mean reader age of 16-17 years. At time of writing, comprehension was assessed in 7 of the planned 100 patients. So far, the mean number of correct answers was 3.2±0.5 (max. score of 5). Conclusions: The ARA PMIS are suitable for readers who have completed a grade level ≥11 with a reading age ≥16 years. A low literacy population (< grade 8) will probably struggle to understand the content. These findings need to be extended to the PMIS used in other countries and has implications for the design of better patient information material. 
